AIIMS Delhi Starts Free Epilepsy Drug Monitoring
AIIMS New Delhi now provides free Therapeutic Drug Monitoring for epilepsy patients, saving costs up to ₹1,880 per test. This move aims to improve treatment outcomes and adherence. Read more.
Category : Search result: Northeast India drugs
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Bollywood Shifts from UP-Bihar to Northeast India
Bollywood is swapping dusty UP-Bihar badlands for the Northeast's lush landscapes and rich folklore. Discover the films, OTT shows, and economic drivers behind this cinematic shift.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
2026 Fitness Trends: AI, Hyrox, Smart Gear in India
Discover the top 5 wellness trends for 2026 in India, from AI-designed workouts and Hyrox races to smarter gear and affordable weight-loss drugs. Stay ahead in your fitness journey!
Weight-loss drugs poised for takeoff, cancer care expands in 2026
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
Stalin Calls for Joint Fight Against Drugs in Tamil Nadu
Tamil Nadu CM M K Stalin demands unified action from Centre & state to curb drug menace. He also urges the art industry to responsibly highlight drug evils. Read more.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Dehradun students demand justice for murdered MBA scholar
After the murder of MBA student Anjel Chakma, Dehradun's Northeast community unites in protest, demanding justice and institutional sensitivity. Read their powerful story.
Aurobindo Pharma buys Khandelwal Labs unit for ₹325 cr
Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
Tripura MLA Demands Anti-Racism Law After Dehradun Attack
Tripura Congress MLA Sudip Roy Barman urges Centre for anti-racism bill after Anjel Chakma's death. Calls for curriculum reform and legal action against racial discrimination targeting NE Indians.
Govt bans oral Nimesulide above 100mg with immediate effect
The Indian government has prohibited the manufacture and sale of high-dose Nimesulide painkillers, citing health risks. Safer alternatives are available. Read the full details and implications.
India's 2025 Travel Trends: OTT, Ayodhya Lead the Way
ixigo's Great Indian Travel Index 2025 reveals key trends: spiritual hubs like Ayodhya surged, OTT series boosted Northeast tourism, and East Asia gained popularity. Discover the year's travel shifts.
2025: The Year Weight-Loss Drugs Redefined Health in India
Explore how 2025's weight-loss drug boom in India shifted focus from fitness to thinness, raising concerns about medicalisation, side effects, and societal pressure. Read the full analysis.
2025: The Year Wellness Became Everyday Life in India
Explore how 2025 cemented wellness into daily Indian life. Discover trends like social fitness, hybrid athletes, padel, weight-loss drugs, and open perimenopause talks. Dive in!
Dehradun MBA Student's Death Sparks Protests Over Racism
The death of Anjel Chakma, a Tripura MBA student in Dehradun, reignites the painful debate on racial hostility faced by Northeast Indians. Why does this discrimination persist?
Anjel Chakma Murder Highlights Normalised Racism in India
The murder of Tripura student Anjel Chakma is a tragic culmination of daily casual racism faced by Northeastern Indians. From slurs to institutional silence, this article examines the systemic issue.
Bengaluru engineer arrested for making drugs at home
A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.
Anjel Chakma Death Highlights Racism Against Northeast
The killing of Anjel Chakma spotlights the daily racism faced by Northeast Indians. Despite demands for an anti-racial law, legal safeguards remain absent, leaving communities vulnerable. Read why justice is delayed.
Akums Finance Head Resigns Citing Delhi Air Pollution
Rajkumar Bafna, Finance President of Akums Drugs, resigns citing severe Delhi pollution as the primary reason. Read the full story on this corporate exit driven by environmental concerns.
Senior Exec Quits Job Over Delhi's Toxic Air Pollution
A senior pharmaceutical executive resigns, citing Delhi's severe air pollution as the primary reason. This drastic move highlights the city's escalating public health emergency. Read more about the human cost of India's air quality crisis.
DCA Raids Quack's Clinic, Seizes Illegal Drugs Worth ₹15,011
Drugs Control Administration officials raided an unlicensed clinic in Karimnagar, seizing illegal steroids and antibiotics. The crackdown highlights the public health risks of unauthorized drug sales. Read more.
India's Growth Linked to Northeast Development
India's strategic and economic future hinges on fully integrating its Northeast region. Discover the untapped potential and the path forward for national prosperity.
Delhi Pollution Leads to High-Profile Resignation
Rajkumar Bafna, President of Finance at Akums Drugs, resigns citing Delhi's toxic air. His case highlights a growing trend of professionals leaving the capital for health reasons. Read the full story.
2025 Weight Loss Trend: Experts Stress Lifestyle Over Injections
As GLP-1 drugs like Ozempic launched in India, experts warn they are not a magic fix. Sustainable metabolic health requires diet, exercise, and stress management. Learn why.
OTT Shows Fuel 2025 Travel Boom to Northeast India
Popular OTT series like The Family Man 3 are inspiring Indians to visit the Northeast. Ixigo's 2025 report reveals a spike in bookings to Imphal, Dimapur & global spots like Japan. Discover the new travel trends!
India's Weight-Loss Drug Market to Grow 10x by 2030
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
3.9 Magnitude Earthquake Hits Bangladesh
A 3.9 magnitude earthquake struck Bangladesh near the Indian border. Tremors were felt in parts of Northeast India. No casualties or damage reported. Stay updated on seismic activity.
Page 1 of 4